BA vs CRWV: Which Is the Better Buy?

Side-by-side comparison of The Boeing Company and CoreWeave, Inc. Class A Common Stock β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-23.
The Boeing Company Β· Industrials
$201.15
+31.7% upside to fair value
Med Conviction Grade B
VS
CoreWeave, Inc. Class A Common Stock Β· Technology
$86.76
+45.0% upside to fair value
Med Conviction Grade B
QuantHub Verdict
CRWV has more upside to fair value (+45.0%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric BA CRWV
Current Price $201.15 $86.76
Fair Value Estimate $265.00 $125.80
Upside to Fair Value +31.7% +45.0%
Market Cap $159.0B $47.3B
Forward P/E β€” β€”
EV / EBITDA 28.4x 36.3x
Price / Sales 1.7x 6.2x
Price / FCF β€” β€”
Revenue Growth YoY +8.0% +112.3%
Gross Margin 4.7% 67.4%
Operating Margin -5.4% -3.0%
Return on Equity 104.8% -45.4%
Dividend Yield 0% 0%
FCF Yield β€” β€”
Analyst Consensus Strong Buy Buy
Investment Thesis
BA β€” The Boeing Company
Boeing is a global aerospace and defense manufacturer spanning commercial airliners, military aircraft, satellites, missile defense, and aftermarket services, with roughly 182,000 employees and a business that remains structurally advantaged by the duopoly economics of large commercial aircraft and the long-cycle, high-switching-cost nature of aerospace platforms. The business quality is currentl…
CRWV β€” CoreWeave, Inc. Class A Common Stock
CoreWeave operates a specialized GPU cloud platform purpose-built for generative AI workloads, offering high-performance GPU and CPU compute, storage, networking, and managed services to large enterprises from bare-metal and virtual server options. The business is growing explosively, with revenue up 112.3% year over year in the most recent quarter and a TTM gross margin of 67.4%, but it is doing…
Accumulation Zones
Metric BA CRWV
Zone Low $198.75 $94.35
Zone High $225.25 $106.93
In Buy Zone? Yes Yes
← BA Research    CRWV Research β†’    All Research